American Shared Hospital Services (AMS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.28, +1.59% vs the prior close of $1.26.
- Volume 27.80K shares, 2.4x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AMS rises 1.6% to $1.28 on 2.4x normal volume. Closed at $1.28, +1.59% vs the prior close of $1.26. Day range $1.21–$1.28, opened at $1.27.
AMS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AMS rises 1.6% to $1.28 on 2.4x normal volume
- Closed at $1.28, +1.59% vs the prior close of $1.26. Day range $1.21–$1.28, opened at $1.27.
- Volume was 27.80K shares, 2.4x its 50-day average of 11.68K — unusually heavy trading.
- Price is -10.9% vs its 50-day average ($1.44) and -22.8% vs its 200-day average ($1.66).
- 52-week range $1.21–$2.39; today's close sits at 6% of that range, 46.4% below the 52-week high.
Oct 15, 2026 — AMS dips 0.8% to $1.26, a 52-week low, 7 down days in a row
- Closed at $1.26, -0.79% vs the prior close of $1.27. Day range $1.26–$1.29, opened at $1.29.
- Volume was 2.60K shares, 0.2x its 50-day average of 11.77K — lighter than usual.
- Price is -12.5% vs its 50-day average ($1.44) and -24.2% vs its 200-day average ($1.66).
- 52-week range $1.21–$2.39; today's close sits at 4% of that range, 47.3% below the 52-week high.
- That makes 7 straight losses.
Oct 14, 2026 — AMS ends flat (+0.0%) to $1.27, 6 down days in a row
- Closed at $1.27, +0.00% vs the prior close of $1.27. Day range $1.21–$1.27, opened at $1.25.
- Volume was 19.00K shares, 1.6x its 50-day average of 11.68K.
- Price is -12.1% vs its 50-day average ($1.45) and -23.8% vs its 200-day average ($1.67).
- 52-week range $1.21–$2.39; today's close sits at 5% of that range, 46.9% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — AMS ends flat (+0.0%) to $1.27, 5 down days in a row
- Closed at $1.27, +0.00% vs the prior close of $1.27. Day range $1.26–$1.28, opened at $1.27.
- Volume was 4.40K shares, 0.4x its 50-day average of 11.76K — lighter than usual.
- Price is -12.4% vs its 50-day average ($1.45) and -24.0% vs its 200-day average ($1.67).
- 52-week range $1.25–$2.39; today's close sits at 2% of that range, 46.9% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — AMS slides 3.8% to $1.27, a 52-week low, 4 down days in a row
- Closed at $1.27, -3.79% vs the prior close of $1.32. Day range $1.27–$1.31, opened at $1.29.
- Volume was 9.10K shares, 0.8x its 50-day average of 12.05K.
- Price is -12.6% vs its 50-day average ($1.45) and -24.2% vs its 200-day average ($1.67).
- 52-week range $1.25–$2.44; today's close sits at 2% of that range, 48.0% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — AMS dips 0.8% to $1.32, a 3-month low, 3 down days in a row
- Closed at $1.32, -0.75% vs the prior close of $1.33. Day range $1.27–$1.32, opened at $1.31.
- Volume was 21.00K shares, 1.8x its 50-day average of 11.77K.
- Price is -9.5% vs its 50-day average ($1.46) and -21.4% vs its 200-day average ($1.68).
- 52-week range $1.25–$2.48; today's close sits at 6% of that range, 46.8% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — AMS dips 1.5% to $1.33, a 3-month low
- Closed at $1.33, -1.48% vs the prior close of $1.35. Day range $1.32–$1.33, opened at $1.33.
- Volume was 3.70K shares, 0.3x its 50-day average of 12.09K — lighter than usual.
- Price is -9.0% vs its 50-day average ($1.46) and -21.0% vs its 200-day average ($1.68).
- 52-week range $1.25–$2.53; today's close sits at 6% of that range, 47.4% below the 52-week high.
Oct 7, 2026 — AMS dips 2.2% to $1.35 on 2.4x normal volume
- Closed at $1.35, -2.17% vs the prior close of $1.38. Day range $1.34–$1.39, opened at $1.36.
- Volume was 30.70K shares, 2.4x its 50-day average of 12.80K — unusually heavy trading.
- Price is -7.8% vs its 50-day average ($1.47) and -19.9% vs its 200-day average ($1.69).
- 52-week range $1.25–$2.58; today's close sits at 8% of that range, 47.7% below the 52-week high.
Oct 6, 2026 — AMS rises 2.2% to $1.38
- Closed at $1.38, +2.22% vs the prior close of $1.35. Day range $1.34–$1.38, opened at $1.35.
- Volume was 4.80K shares, 0.4x its 50-day average of 13.06K — lighter than usual.
- Price is -6.1% vs its 50-day average ($1.47) and -18.3% vs its 200-day average ($1.69).
- 52-week range $1.25–$2.58; today's close sits at 10% of that range, 46.5% below the 52-week high.
Oct 5, 2026 — AMS slides 4.3% to $1.35, a 3-month low
- Closed at $1.35, -4.26% vs the prior close of $1.41. Day range $1.35–$1.40, opened at $1.40.
- Volume was 12.40K shares, 0.9x its 50-day average of 13.11K.
- Price is -8.3% vs its 50-day average ($1.47) and -20.3% vs its 200-day average ($1.69).
- 52-week range $1.25–$2.59; today's close sits at 7% of that range, 47.9% below the 52-week high.
Oct 2, 2026 — AMS dips 1.4% to $1.41, a 1-month low
- Closed at $1.41, -1.40% vs the prior close of $1.43. Day range $1.41–$1.43, opened at $1.42.
- Volume was 3.60K shares, 0.3x its 50-day average of 13.17K — lighter than usual.
- Price is -4.4% vs its 50-day average ($1.48) and -16.9% vs its 200-day average ($1.70).
- 52-week range $1.25–$2.59; today's close sits at 12% of that range, 45.6% below the 52-week high.
AMS latest news & SEC filings
Every SEC filing by or about AMS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $8.43M (prior year $7.07M) (+19.2% vs Jun 30, 2025)
- Net income: -$514.00K (prior year -$280.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.07 (prior year -$0.04) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 30, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Jun 25, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stachowiak Raymond C bought 586,468 shares at $2.28 (≈$1.34M) on Jun 22, 2026
- Stachowiak Raymond C bought 586,468 shares at $2.28 (≈$1.34M) on Jun 22, 2026
- Stachowiak Raymond C bought 586,468 shares at $2.28 (≈$1.34M) on Jun 22, 2026
- Stachowiak Raymond C bought 586,468 shares at $2.28 (≈$1.34M) on Jun 22, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 23, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade AMS
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 31, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.51% (largest 4.3%).
- Liquidity: about 10.52K shares (≈$13.47K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.28 vs a range of $1.21–$2.39 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Raymond C Stachowiak bought 586,468 shares on Jun 22, 2026.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 13, 2026; 8-K Jul 28, 2026.
- Share count: 6.65M shares outstanding (Aug 11, 2026), +2.2% vs a year earlier.
- Listing: NYSE · industry: Services-Medical Laboratories.
AMS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.27 | 1.28 | 1.21 | 1.28 | 27.80K |
| Oct 15, 2026 | 1.29 | 1.29 | 1.26 | 1.26 | 2.60K |
| Oct 14, 2026 | 1.25 | 1.27 | 1.21 | 1.27 | 19.00K |
| Oct 13, 2026 | 1.27 | 1.28 | 1.26 | 1.27 | 4.40K |
| Oct 12, 2026 | 1.29 | 1.31 | 1.27 | 1.27 | 9.10K |
| Oct 9, 2026 | 1.31 | 1.32 | 1.27 | 1.32 | 21.00K |
| Oct 8, 2026 | 1.33 | 1.33 | 1.32 | 1.33 | 3.70K |
| Oct 7, 2026 | 1.36 | 1.39 | 1.34 | 1.35 | 30.70K |
| Oct 6, 2026 | 1.35 | 1.38 | 1.34 | 1.38 | 4.80K |
| Oct 5, 2026 | 1.40 | 1.40 | 1.35 | 1.35 | 12.40K |
| Oct 2, 2026 | 1.42 | 1.43 | 1.41 | 1.41 | 3.60K |
| Oct 1, 2026 | 1.43 | 1.43 | 1.42 | 1.43 | 7.70K |
| Sep 30, 2026 | 1.46 | 1.46 | 1.42 | 1.42 | 16.30K |
| Sep 29, 2026 | 1.43 | 1.45 | 1.43 | 1.44 | 1.20K |
| Sep 28, 2026 | 1.42 | 1.43 | 1.42 | 1.43 | 11.40K |
| Sep 25, 2026 | 1.45 | 1.46 | 1.42 | 1.42 | 13.20K |
| Sep 24, 2026 | 1.45 | 1.49 | 1.45 | 1.46 | 10.80K |
| Sep 23, 2026 | 1.46 | 1.47 | 1.45 | 1.45 | 6.40K |
| Sep 22, 2026 | 1.45 | 1.47 | 1.42 | 1.47 | 2.40K |
| Sep 21, 2026 | 1.47 | 1.47 | 1.43 | 1.45 | 1.90K |
About American Shared Hospital Services
American Shared Hospital Services (AMS) is listed on the NYSE and classified by the SEC under “Services-Medical Laboratories”. Its business address is in SAN FRANCISCO, CA. State of incorporation: CA. Fiscal year ends December 31. SEC CIK 744825.
AMS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Raymond C Stachowiak | Executive Chairman | Jul 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Raymond C Stachowiak | Executive Chairman | Jul 24, 2026 |
| Alexis Tirrito | Interim CFO, CAO and Secretary | Jul 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | Raymond C Stachowiak | Buy | 586,468 | $2.28 |
| Jun 22, 2026 | Raymond C Stachowiak | Buy | 586,468 | $2.28 |
| Jun 22, 2026 | Raymond C Stachowiak | Buy | 586,468 | $2.28 |
| Jun 22, 2026 | Raymond C Stachowiak | Buy | 586,468 | $2.28 |
AMS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $28.08M | $-1.55M | -0.23 | $3.10M |
| Dec 31, 2024 | $28.34M | $2.19M | 0.33 | $167.00K |
| Dec 31, 2023 | $21.32M | $610.00K | 0.10 | $5.72M |
| Dec 31, 2022 | $19.75M | $1.33M | 0.21 | $7.24M |
| Dec 31, 2021 | $17.63M | $194.00K | 0.03 | $6.27M |
Latest balance sheet: total assets $52.49M, total liabilities $26.68M, cash $6.51M (as of Jun 30, 2026).
AMS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.60 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.58 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $1.45 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $2.24 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $2.58 |
| May 15, 2025 | 8-K Item 2.02 (results) | $2.68 |
| Apr 4, 2025 | 8-K Item 2.02 (results) | $3.00 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $2.85 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AMS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.